$
Federal Contract Award
Teva Pharmaceuticals USA, INC.
Department of Defense · May 11, 2026 · FY2026
SPE2DP26F5471Set-aside not reportedNAICS 325412
Obligated
$515,290
Contract details
- Award ID
- CONT_AWD_SPE2DP26F5471_9700_SPE2DP20D0002_9700
- PIID
- SPE2DP26F5471
- Period of performance
- May 11, 2026 → May 19, 2026
- Place of performance
- PARSIPPANY, NJ, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
Scope
8512097411!ADENOVIRUS TYPE 4 A
Parent vehicle (IDV)
Teva Pharmaceuticals USA, INC.
UEI NEN9A34LRHJ5
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Teva Pharmaceuticals USA, INC. →- UEI
- NEN9A34LRHJ5
- CAGE
- 3V8D7
- Parent
- Teva Pharmaceuticals USA, INC.
- Address
- NORTH WALES, PA
Awarding agency
Department of Defense →- Sub-agency
- Defense Logistics Agency
- Office
- DLA TROOP SUPPORT
- Funding agency
- Department of Defense
- Funding office
- DLA TROOP SUPPORT
See every contract Teva Pharmaceuticals USA, INC. has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Teva Pharmaceuticals USA, INC. profile →